View in EDS HTML Full Text PDF Full Text

Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.

Saved in:
Bibliographic Details
Title: Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Authors: Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Srour SA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mendoza T; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Whisenant M; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Research, Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Subbiah I; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gonzalez E; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kamal M; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shen SE; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cleeland C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Neelapu S; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ahmed S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Source: British journal of haematology [Br J Haematol] 2023 May; Vol. 201 (4), pp. 738-746. Date of Electronic Publication: 2023 Feb 02.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36733986
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+XS%22">Wang XS</searchLink>; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Srour+SA%22">Srour SA</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Mendoza+T%22">Mendoza T</searchLink>; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Whisenant+M%22">Whisenant M</searchLink>; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Research, Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Subbiah+I%22">Subbiah I</searchLink>; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez+E%22">Gonzalez E</searchLink>; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kamal+M%22">Kamal M</searchLink>; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Shen+SE%22">Shen SE</searchLink>; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Cleeland+C%22">Cleeland C</searchLink>; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kebriaei+P%22">Kebriaei P</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Rezvani+K%22">Rezvani K</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Neelapu+S%22">Neelapu S</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Ahmed+S%22">Ahmed S</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Shpall+E%22">Shpall E</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2023 May; Vol. 201 (4), pp. 738-746. <i>Date of Electronic Publication: </i>2023 Feb 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36733986
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.18677
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 738
    Titles:
      – TitleFull: Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang XS
      – PersonEntity:
          Name:
            NameFull: Srour SA
      – PersonEntity:
          Name:
            NameFull: Mendoza T
      – PersonEntity:
          Name:
            NameFull: Whisenant M
      – PersonEntity:
          Name:
            NameFull: Subbiah I
      – PersonEntity:
          Name:
            NameFull: Gonzalez E
      – PersonEntity:
          Name:
            NameFull: Kamal M
      – PersonEntity:
          Name:
            NameFull: Shen SE
      – PersonEntity:
          Name:
            NameFull: Cleeland C
      – PersonEntity:
          Name:
            NameFull: Kebriaei P
      – PersonEntity:
          Name:
            NameFull: Rezvani K
      – PersonEntity:
          Name:
            NameFull: Neelapu S
      – PersonEntity:
          Name:
            NameFull: Ahmed S
      – PersonEntity:
          Name:
            NameFull: Shpall E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2023 May
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 201
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1